Monthly Summary Report · Month 4
Alex Rivera
Traffic Light Dashboard
Auto-generated from trajectory fields. Your whole month in one glance, before you read a word.
Heart Rate Variability
▲ +3.7 ms
Resting Heart Rate
▼ −3.0 bpm
Sleep Duration
▲ +0.5 h
Sleep Efficiency
▲ +3.0 pts
Step Count
▲ +950
Oura Readiness
▲ one band
Trending Well Holding Steady / Optimising Worth Watching Needs Follow-UpValues shown are Month 4 averages; arrows compare against Month 3.
Executive Summary
Holding Steady
- Urgency indicatorRoutine — nothing time-sensitive this month
- Interpretation phasePhase 1 — Establishment (late)
- Comparison basisYour personal baseline and your own prior months — never population norms
- DeviceOura Ring (sole device this month)
Your travel weeks are the single largest recurring cost in your data. Both recommendations this month are aimed at that one thing, and cycles 17 and 18 are where I will read them.
For the next cycle — Dr. S. Kapoor, MBBS (illustrative)What Changed
Month 4 covered four cycles that were anything but routine: cycle 13 closed your first quarter, cycle 14 was your 10K, cycle 15 was a work trip, and cycle 16 was recovery.
Three things changed measurably against Month 3.
Your HRV month average returned to 48.0 ms — exactly your established baseline — from 44.3 ms in Month 3. That is a 3.7 ms recovery in a single month, and it is the first month since Month 1 that has closed at baseline rather than below it.
Your resting heart rate averaged 55.0 bpm, three points below Month 3 and one point below your baseline of 56. It is the lowest month you have recorded.
Your sleep recovered on both dimensions. Duration averaged 7.2 hours against 6.7 in Month 3; efficiency averaged 90 % against 87 %. Both are back to baseline rather than above it.
Your step count averaged 9,750 per day, the highest month so far, though cycle 14's 11,400 is a single event week and should not be read as a new normal.
What did not change: your travel week still costs you. Cycle 15 sat at 44 ms HRV and 87 % sleep efficiency — a real dip, and the same shape as cycle 6.
Why It Likely Changed
Two things ended in Month 3, and one thing you did in cycle 11 carried into Month 4.
The demanding work period that ran through cycles 9 to 11 finished. That period produced the Sleep Debt Cascade signature — sleep opportunity compressing first, sleep efficiency following, HRV declining behind both — and it was the dominant influence on Month 3. Its ending is the largest single reason Month 4 reads better.
In cycle 11 you reduced your weekly running volume by roughly a third, on my recommendation, after your data showed the Training Overreach Signal: rising load with recovery markers moving the wrong way. You held that reduction through cycles 12 and 13. Your HRV moved 43 → 47 → 51 ms across those three cycles. That is a clean response, and it is why cycle 13 closed your quarter at your highest reading of the year so far.
The cycle 15 dip is your Travel Recovery Profile again. What is worth noticing is its shape rather than its depth. In cycle 6 the same pattern took about five days to resolve. In cycle 15 it took about three, and cycle 16 closed at 50 ms with 91 % efficiency. One faster recovery is not yet a trend — but it is the first time your data has come back quicker than the previous instance.
I would not attribute the 10K itself much influence either way. Event weeks raise activity and lower recovery briefly; cycle 14 did both and resolved without a mark on the month.
4-Week Trend Charts
Heart Rate Variability — cycles 13–16
Line chart with shaded personal baseline band (48.0 ± 2.6 ms)
Two cycles inside the baseline band, one at the upper edge, one below it. The dip is real and explained; the return is faster than the equivalent dip in cycle 6.
Resting Heart Rate — cycles 13–16
Line chart with shaded personal baseline band (56.0 ± 1.4 bpm)
Three of four cycles at or below baseline. Lower is the favourable direction here.
Sleep Duration — cycles 13–16
Line chart with shaded personal baseline band (7.2 ± 0.3 h)
Sleep Efficiency — cycles 13–16
Line chart with shaded personal baseline band (90 ± 1.8 %)
Read directionally, not precisely — see the confidence grade below.
Step Count — cycles 13–16
Line chart with shaded personal baseline band (8,700 ± 390 /day)
Month-Level Metric Summary
| Metric | Month 4 | Month 3 | Month 2 | Month 1 | Personal baseline |
|---|---|---|---|---|---|
| Heart Rate Variability | 48.0 ms | 44.3 ms | 45.8 ms | 48.0 ms | 48.0 ms |
| Resting Heart Rate | 55.0 bpm | 58.0 bpm | 56.5 bpm | 56.0 bpm | 56.0 bpm |
| Sleep Duration | 7.2 h | 6.7 h | 7.0 h | 7.2 h | 7.2 h |
| Sleep Efficiency | 90.0 % | 87.0 % | 88.8 % | 90.0 % | 90.0 % |
| Step Count | 9,750 | 8,800 | 9,050 | 8,700 | 8,700 |
Confidence & Device Reliability
Physician-authored at this tier, not merely confirmed.
| Metric | Grade | Reason — required below A |
|---|---|---|
| Heart Rate Variability | A | — |
| Resting Heart Rate | A | — |
| Step Count | A | Among the more reliable consumer measurements across device categories. |
| Sleep Duration | B | Cycle 15 carried two nights of incomplete overnight wear during travel. |
| Sleep Efficiency | C | Consumer sleep-stage detection is meaningfully less accurate than clinical sleep-study measurement, and cycle 15's incomplete wear compounds it. Directional only. |
| Oura Readiness | B | A proprietary composite; its individual inputs are not exposed, so it is read as a band rather than a value. |
Device reliability, Month 4: Oura Ring, sole device, 93 % wear compliance across 28 nights. No firmware changes during the month. No cross-device reconciliation required this month.
Lifestyle Correlation Analysis
This table is unique to you. No wearable app can produce it — because no wearable app has your physician team's weekly context data about what was happening in your life when your metrics shifted.
Computed from 16 weeks of your own submissions. Pearson correlation.
| Lifestyle factor | Direction | Metric affected | Strength |
|---|---|---|---|
| Nights away from home (travel) | ▼ Negative | Heart Rate Variability | r = −0.68 · strong |
| Weeknight lights-out consistency | ▲ Positive | Sleep Efficiency | r = +0.61 · moderate-to-strong |
| Self-reported work-demand rating | ▼ Negative | Sleep Duration | r = −0.57 · moderate |
How to read this, and how not to
These are statistical relationships in your own data over sixteen weeks. They describe what has moved together, not what has caused what. A correlation of −0.68 between travel nights and HRV does not establish that travel lowers your HRV; it establishes that in your record, the two reliably move in opposite directions. That distinction matters, and I will not write past it.
What all three rows point at is the same lever: the protection of your sleep window during the weeks when your schedule is least under your control.
Correlation Heat Map
Green = favourable relationship · white = no relationship · red = unfavourable relationship. Pearson r over 16 weeks.
| Factor | HRV | Resting HR | Sleep duration | Sleep efficiency | Steps |
|---|---|---|---|---|---|
| Travel nights | −0.68 | +0.54 | −0.62 | −0.59 | +0.18 |
| Lights-out consistency | +0.44 | −0.31 | +0.49 | +0.61 | +0.05 |
| Work-demand rating | −0.51 | +0.42 | −0.57 | −0.44 | −0.22 |
| Running volume | −0.12 | −0.28 | +0.08 | +0.11 | +0.74 |
Note on the resting-heart-rate column: a rising resting heart rate is the unfavourable direction, so the colour scale is inverted for that column and the visual reading stays consistent across the map.
Note on the bottom row: the +0.74 between running volume and step count is definitional rather than informative — running produces steps. It is shown for completeness and carries no interpretive weight.
Clinical Note
Alex — Month 4 is the first month where I can show you something other than a description of what happened: I can show you what your own data has started to predict.
Your month average for HRV came back to 48 ms — exactly your established baseline — after Month 3 spent well below it at 44.3. Your resting heart rate averaged 55 bpm, the lowest month you have had, and three points below Month 3. Sleep duration recovered to 7.2 hours from 6.7. None of those numbers is dramatic on its own. Together, and read against the month that preceded them, they say your recovery capacity absorbed a demanding four weeks and came back.
Those four weeks were not quiet. Cycle 14 was your 10K. Cycle 15 was a work trip. That combination — an event week immediately followed by three nights away — is the kind of sequence that produced a five-day recovery in cycle 6. This time it produced a three-day one, and by cycle 16 you were at 50 ms with a sleep efficiency of 91 per cent.
I want to be careful about how much I claim from that. Four months is a short observation window, and one favourable sequence is not proof of durable change. What I can say is that it is consistent with every cycle since you reduced running volume in cycle 11.
The correlation table on the previous page is the part of this report I would ask you to spend the most time with. It is built from sixteen weeks of your own submissions, not from population averages, and it says three things. Travel nights track with lower HRV, strongly. Consistent weeknight lights-out timing tracks with better sleep efficiency, moderately. Higher self-reported work demand tracks with shorter sleep. None of these is a cause — a statistical relationship in your data cannot establish that — but all three point at the same lever, which is the protection of your sleep window when your schedule is least under your control.
On data quality: your sleep-efficiency grade is a C this month, and the reason is worth stating plainly. Consumer sleep-stage detection is meaningfully less accurate than a clinical sleep study, and cycle 15 added two nights of incomplete ring wear on top of that. I read your sleep-efficiency trend as directional, not precise. Your HRV, resting heart rate and step data all carry an A this month and can be read at face value.
Nothing in this month suggests anything requiring medical attention, and nothing here is a diagnosis. If you were to mention one thing to your own doctor at a routine visit, it would simply be that you now have four months of consistent overnight cardiovascular and sleep data available — useful context for them to have, not a concern to raise.
Two recommendations follow. Both are aimed at the same thing: making your travel weeks cost you less. Cycle 17 and cycle 18 are the cycles I will read them against, and I will tell you explicitly in next month's report whether they moved anything.
— Dr. S. Kapoor, MBBS (illustrative physician · sample report)
Clinical note: 572 words. Monthly enforced range 400–600 words.
Follow-Through & Next Steps
Recommendation Lifecycle — status update
| Recommendation | Issued | Stage | Movement |
|---|---|---|---|
| Reduce weekly running volume by roughly a third until recovery markers stabilise | Cycle 11 | Completed — sustained | HRV 43 → 47 → 51 ms across cycles 11–13 |
| Protect a 7-hour sleep opportunity on at least 5 nights weekly | Cycle 10 | Active — holding | Sleep duration 6.3 → 7.4 h, cycles 10 → 13 |
| Anchor weeknight lights-out within 30 minutes of usual | Cycle 5 | Active — partial | Holds at home; does not survive travel weeks. Superseded by Recommendation A below. |
New Recommendation A — Travel Sleep Anchor
New Recommendation B — Post-Event Recovery Window
When to mention something to your own doctor
Nothing this month warrants raising a concern. At a routine appointment, it is simply useful for your doctor to know you have four months of consistent overnight cardiovascular and sleep data available. This is context, not a referral, and not a diagnosis.
How AI Was Used in This Report
Artificial intelligence is used in preparing this report to organise and compute — never to interpret. It assembles your data, calculates trends and comparisons against your own baseline, and produces a provisional data-quality grade for a physician to confirm or override. It does not write clinical judgement. No AI-drafted text is presented to you as your physician's voice. Every interpretation, every recommendation, and every word of the clinical narrative in this report was written by a named physician.
| In this report | Computed by AI | Reviewed by physician | Authored by physician |
|---|---|---|---|
| Traffic Light Dashboard | Fully automated | No physician time required | — |
| Month-level metric synthesis | Yes | Confirmed | — |
| 4-week trend charts | Chart pipeline | Accuracy confirmed | — |
| Correlation table & heat map | Pearson computation | Contextualised, not computed, by the physician | — |
| Confidence grades | — | — | Physician-authored at this tier |
| What Changed / Why It Likely Changed | No | — | 100 % physician |
| Clinical note | Never | — | 100 % physician |
| Recommendations | No | — | 100 % physician |
Reviewed By + QA Certification
Provider Summary
Sixteen weeks of continuous consumer wearable data, physician-reviewed weekly. Comparison is against the subscriber's own baseline (cycles 1–4), not population norms.
| Metric | Baseline | Month 4 | Direction |
|---|---|---|---|
| HRV (overnight) | 48.0 ms | 48.0 ms | At baseline |
| Resting HR | 56 bpm | 55.0 bpm | ▼ favourable |
| Sleep duration | 7.2 h | 7.2 h | At baseline |
| Sleep efficiency | 90 % | 90.0 % | At baseline |
| Steps | 8,700/day | 9,750/day | ▲ |
Clinically relevant notes
No flagged abnormality across 16 weeks. Month 3 showed a transient decline (HRV 44.3 ms, sleep 6.7 h) coinciding with a documented high-workload period, fully resolved by Month 4. Recurrent short-duration declines coincide with monthly business travel and resolve within 3–5 days.
Data quality
HRV, resting HR and step data graded A. Sleep-efficiency data graded C — consumer sleep-staging is not equivalent to polysomnography and should be read directionally.
Scope
Wellness monitoring only. No diagnosis, no treatment recommendation, and no medication guidance has been provided to this subscriber. This summary is offered as context for your own assessment, not as a clinical finding.
Next Report
Your Month 5 Summary arrives Tuesday 27 May 2025, covering cycles 17–20. It will carry the first read on both recommendations above, and it is the month your Garmin device joins the record — which will bring a note on how WWG reconciles two devices that measure the same thing differently.
Your weekly cycles continue uninterrupted in the meantime, and your first Quarterly Physician Letter has already covered cycles 1–13.